Try our Advanced Search for more refined results

Ranbaxy Wins FDA Approval To Sell Generic Diovan

By David Siegel (June 27, 2014, 6:44 PM EDT) -- Ranbaxy Laboratories Ltd. announced Friday that it had received permission from the U.S. Food and Drug Administration for a subsidiary to begin selling a generic version of the widely prescribed blood pressure medication Diovan on an exclusive basis, after the agency initially delayed approval due to safety concerns....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!